USPTO serial 86465357
STRATACOR
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BESCH, JAY C
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with STRATACOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ruth Rivard
Ruth Rivard Stinson Leonard Street LLP150 South 5th Street, Ste 2300Minneapolis, MN 55402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, chemicals for use in industry and science, and chemicals for use in the manufacture of cosmetics, pharmaceuticals, medical devices; Chemical ingredients for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, active chemical ingredients for use in the manufacture of pharmaceuticals for treating wounds, treating infectious disease, and chemical additives for use as cleansing, deodorizing and refreshing ingredients in the manufacture of mouth sprays, dental cements and medicines for dental purpose; Adhesives for use in the medical, dental, vision, health, healthcare, veterinary, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, adhesives for use in industry and adhesives other than for stationery or household purposes; Antioxidants, namely, antioxidants for use in the manufacture of a wide variety of goods; Proteins, namely, proteins for use in the manufacture of a wide variety of goods; Protein arrays and nucleotide arrays for scientific and medical research; Protein for industrial use; Protein in raw material form for scientific and medical research; Biochemicals, namely, biochemical catalysts, biochemical reagents used for non-medical purposes, biochemical for in vitro and in vivo scientific use, and chemicals for use in the biochemical and chemical industry; Biological tissue for laboratory, research, clinical or medical laboratory use, namely, biological tissue cultures other than for medical or veterinary purposes, blood, stem cells, umbilical cords and placentas for scientific and medical research use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory, research, clinical or medical laboratory use; Cells for laboratory, research, clinical or medical laboratory use; Ceramic compositions for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, ceramic compositions in the solid state for manufacture of fibrous monolithic ceramic compartments for use in high temperature applications; Chemical agents for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, chemical agents for chelating and sequestering, and chemical agents for removing acid in industrial manufacturing application; Chemical compounds for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, chemical compositions for solidification of fluids, metal plating chemical compositions, and waterproofing chemical compositions; Chemical preparations for use in the medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, chemical preparations for use in industry, chemical preparations for use in medical device industry, chemical preparations for scientific purposes, chemical additives for use in the manufacture of cosmetics and pharmaceuticals; Chemical products for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, chemical agents for chelating and sequestering, chemical agents for removing acid in industrial manufacturing applications, chemical products for preventing scale, and chemical products for stabilizing foodstuffs; Chemical reagents for laboratory, research, clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations other than for medical or veterinary purposes; Diagnostic reagents for laboratory, research, clinical or medical laboratory use; Enzymes for industrial purposes; enzymes for scientific and research purposes; Minerals for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, mineral substances in the nature of sorbents,sulphur,huntite used in industry, hydromagnesite used in industry, and mineral substances used to oxidize impurities and regulate temperatures in glass production furnaces; Metals for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, alkaline metals, and rare earth metals; Plant and herb extracts for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, plant and herb extracts for use in the manufacture of creams, lotions and cosmetic products; Plastics for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields, namely, protein plastics, unprocessed plastics in all forms; Polymers, namely, unprocessed polymers, acrylic polymer powders, polymer beads for use in manufacturing, and polymer compositions used in the manufacture of commercial and industrial goods; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical, dental, and vision devices, cosmetics, personal care products, coatings, adhesives, and lubricants; Stem cells other than for medical or veterinary use; Resins, namely, unprocessed artificial and synthetic resins for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory, research, clinical or medical laboratory use for use in the medical, dental, vision, health, healthcare, veterinary, medical device, wellness, cosmetic, pharmaceutical, industrial and scientific fields; Biological tissue, namely, SHED stem cells (stem cells from human exfoliated deciduous teeth), dental pulp and human maxiofacial bone elements for scientific use and research in cellular healing therapies; Chemical additives for use as cleansing, deodorizing and refreshing ingredients in the manufacture of mouth sprays, dental cements and medicines for dental purposes; Diagnostic preparations for clinical or medical laboratory use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 10, 2017 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 10, 2017 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 20, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 20, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 6, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 12, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 12, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 22, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 3, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 27, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 27, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 27, 2016 | ALIE | ASSIGNED TO LIE | — |
| May 27, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 27, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 27, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 28, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 27, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 2016 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 3, 2015 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 3, 2015 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 3, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 19, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 18, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 18, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 18, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 4, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 29, 2014 | NWAP | NEW APPLICATION ENTERED | — |